resiquimod has been researched along with Hay Fever in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amer, A; Boghdadi, G; Hammad, N; Sammour, S; Sorour, S | 1 |
| Anton, K; Frotscher, B; Worm, M | 1 |
2 other study(ies) available for resiquimod and Hay Fever
| Article | Year |
|---|---|
R848, a Toll-like receptors 7 and 8 agonist, a potential therapy for allergic rhinitis patients.
Topics: Adult; Allergens; Anti-Allergic Agents; Anti-Inflammatory Agents; Cells, Cultured; Cytokines; Female; Humans; Imidazoles; Inflammation Mediators; Male; Middle Aged; Phoeniceae; Plant Proteins; Pollen; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2014 |
Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors.
Topics: Adult; Antibodies, Monoclonal; B-Lymphocytes; CD40 Antigens; Cell Division; Dermatitis, Atopic; Down-Regulation; Humans; Imidazoles; Immunoglobulin E; In Vitro Techniques; Interferon-gamma; Interleukin-12; Interleukin-4; Receptors, IgE; Rhinitis, Allergic, Seasonal; Up-Regulation | 2002 |